A Study of the Concurrent Use of AGN-190584 and AGN-199201 in Participants With Presbyopia
Study Identifier
199201-009
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Results Available
Statistical Analysis Plan
Available Language(s): English
Protocol
Available Language(s): English
Study Details
Medical Condition
Study Drug
Phase
Phase 2
Sex
Female & Male
Age
40 - 50 Years
Protocol Summary
This study will identify the optimum concentrations of AGN-199201 and AGN-190584 when dosed in combination once a day for the improvement of uncorrected near visual acuity in participants with presbyopia (inability to focus on items close-up).
Study Locations
Location
Status
Location
Sall Research Medical Center
Artesia, California, United States, 90701
Status
Not applicable
Location
Milton M. Hom, OD, FAAO
Azusa, California, United States, 91702
Status
Not applicable
Location
WCCT Global, LLC
Costa Mesa, California, United States, 92626
Status
Not applicable
Location
The Eye Research Foundation
Newport Beach, California, United States, 92663
Status
Not applicable
Location
North Bay Eye Associates, Inc.
Petaluma, California, United States, 94954
Status
Not applicable
Location
Martel Eye Medical Group
Rancho Cordova, California, United States, 95670
Status
Not applicable
Showing {first} - {last} of {total} Results